Founded in 2011, Premas Life Sciences operates in Health Tech offering cutting edge solutions to the Indian Research and Applied Markets. The company is focused on providing innovative products and se...
Company Type:
Bootstrapped
Revenue:
₹309.7 Cr+ (FY25)
₹309.7 Cr+ (FY25)
Employee count:
128
Last 90d
128
Last 90d
Web traffic:
1.21K
1.21K
Last 30d
Last 30d
Premas Life Sciences: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders11
Latest Filing Date30 March 2023- Funding Events20
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Premas Life Sciences
As of 31 March 2023, Premas Life Sciences's equity is held by 10 shareholders, with the top three being Praveen Gupta, Avijit Das, and New Horizon Technologies.
Praveen Gupta holds the largest stake in Premas Life Sciences at 29.7% as of 31 March 2023.
As of 31 March 2023, founders collectively hold 54.5% equity in Premas Life Sciences.
As of 31 March 2023, investors collectively hold 2.3% equity in Premas Life Sciences.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links